Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clarus Corp (NQ: CLAR )

6.250 -0.030 (-0.48%)
Streaming Delayed Price Updated: 2:48 PM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarus Corp

< Previous 1 2 3 4 5 Next >
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Thursday Is Your Last Chance To Buy Clarus Before The Dividend Payout
Via Benzinga
Clarus Files Lawsuit Against Caption Management LLC, Caption Partners II LP, Caption GP, LLC, William Cooper and Jason Strasser for Recovery of Short-Swing Profits
From Clarus Corporation
Via GlobeNewswire
Clarus Corp. (NASDAQ: CLAR) Highlighted for Surprising Price Action
Via Investor Brand Network
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Via Benzinga
Clarus: Q4 Earnings Insights
Via Benzinga
Friday Is Your Last Chance To Buy Clarus Before The Dividend Payout
Via Benzinga
Clarus Board of Directors Approves Two of Its Top Shareholders to Increase Their Positions up to 15.0% and 26.7% of Shares Outstanding
From Clarus Corporation
Via GlobeNewswire
Roger Werner Appointed to Clarus’ Board of Directors
From Clarus Corporation
Via GlobeNewswire
CLAR Stock Earnings: Clarus Misses EPS, Misses Revenue for Q4 2023
CLAR stock results show that Clarus missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Clarus Reports Fourth Quarter and Full Year 2023 Results
From Clarus Corporation
Via GlobeNewswire
Clarus: Q3 Earnings Insights
Via Benzinga
Analyst Ratings for Clarus
Via Benzinga
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
Clarus Completes Sale of Precision Sport Segment to JDH Capital
Successful Outcome that Strengthens Balance Sheet and Positions the Company as a Pure-Play Outdoor Business 
From Clarus Corporation
Via GlobeNewswire
Clarus Announces Fourth Quarter and Full Year 2023 Conference Call and Upcoming Investor Day
From Clarus Corporation
Via GlobeNewswire
Few Aspects Of Clarus' Sales Of Precision Sport Segment Seems Odd, Says Analyst
Raymond James analyst Joseph Altobello reiterated a Market Perform rating on the shares of Clarus Corp (NASDAQ: CLAR).  
Via Benzinga
Clarus Enters into Definitive Agreement to Sell Precision Sport Segment
From Clarus Corporation
Via GlobeNewswire
Clarus Reports Status of HAP Trading Short-Swing Profit Litigation
From Clarus Corporation
Via GlobeNewswire
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Clarus Reports Third Quarter 2023 Results
From Clarus Corporation
Via GlobeNewswire
Clarus Announces $0.025 Per Share Quarterly Dividend
From Clarus Corporation
Via GlobeNewswire
Clarus Sets Third Quarter 2023 Conference Call for Tuesday, November 7, 2023, at 5:00 p.m. ET
From Clarus Corporation
Via GlobeNewswire
Clarus Acquires TRED Outdoors, a Fast-Growing Outdoor Adventure Brand
From Clarus Corporation
Via GlobeNewswire
Special Committee of Clarus Retains Houlihan Lokey as Financial Advisor
From Clarus Corporation
Via GlobeNewswire
Clarus Confirms Receipt of Non-Binding Indication of Interest Regarding Precision Sport Segment
From Clarus Corporation
Via GlobeNewswire
12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Fostering Confidence: Clarus Reliable Progress and Investor Expectations
Today, August 25, 2023, marks an important moment for investors of Clarus (NASDAQ:CLAR). The company will distribute a dividend payout of $0.03 per share, demonstrating an annualized dividend yield of... 
Via Benzinga
Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.